INS and metabolic dysfunction-associated steatotic liver disease: The medication for NAFLD treatment includes lipid-lowering and insulin sensitizing drugs, but these agents have certain disadvantages such as sodium retention, weight gain, increased serum transaminase and insulin resistance after drug withdrawal.